Biopharmaceutical company iBio Inc., which is developing a so-called next-generation coronavirus vaccine, is looking for a buyer in a sale-leaseback deal that includes the potential expansion of its campus in Texas.
Biopharma Firm Seeks Real Estate Partner To Buy Facility Near Texas A&M University
Savills Subsidiary Tapped To Help iBio Inc. in Search for Developer To Assist With Future Expansions
By Marissa Luck
CoStar News
December 2, 2021 | 9:25 P.M.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In